End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,15,800 KRW | +1.31% |
|
+1.05% | -7.73% |
10/06 | FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A | CI |
20/05 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GC BIOPHARMA CORP. | Other Pharmaceuticals | +1.31% | +1.05% | -7.73% | +0.87% | -7.73% | 955M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- A006280 Stock
- Charts GC Biopharma Corp.
- Relative Strength Chart